Intervals Between PCV13 and PPSV23 Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP)

MMWR. Morbidity and Mortality Weekly Report
Miwako KobayashiTamara Pilishvili

Abstract

Two pneumococcal vaccines are currently licensed for use in the United States: the 13-valent pneumococcal conjugate vaccine (PCV13 [Prevnar 13, Wyeth Pharmaceuticals, Inc., a subsidiary of Pfizer Inc.]) and the 23-valent pneumococcal polysaccharide vaccine (PPSV23 [Pneumovax 23, Merck and Co., Inc.]). The Advisory Committee on Immunization Practices (ACIP) currently recommends that a dose of PCV13 be followed by a dose of PPSV23 in all adults aged ≥65 years who have not previously received pneumococcal vaccine and in persons aged ≥2 years who are at high risk for pneumococcal disease because of underlying medical conditions (Table) (1-4). The recommended intervals between PCV13 and PPSV23 given in series differ by age and risk group and the order in which the two vaccines are given (1-4).

References

Nov 21, 2007·AIDS·Philippe LespritUNKNOWN ANRS 114-Pneumovac Study Group
May 1, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Andrés de RouxH M Lode
Jun 16, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Karen M MiernykAlan J Parkinson
Oct 10, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David GoldblattElizabeth Miller
Mar 4, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Rajeka LazarusAndrew J Pollard

❮ Previous
Next ❯

Citations

Feb 4, 2016·Human Vaccines & Immunotherapeutics·Anne Devi WoldAnneMarie Beardsworth
Feb 6, 2016·MMWR. Morbidity and Mortality Weekly Report·David K KimUNKNOWN Advisory Committee on Immunization Practices (ACIP), ACIP Adult Immunization Work Group
Feb 24, 2016·Human Vaccines & Immunotherapeutics·Ruth Gil-PrietoÁngel Gil-De-Miguel
Dec 15, 2015·Expert Review of Vaccines·Raul E IsturizPeter Paradiso
Mar 24, 2016·Travel Medicine and Infectious Disease·Riccardo PedersiniJeffrey Vietri
Oct 16, 2015·BMC Infectious Diseases·Tia SorrellChad K Porter
Apr 12, 2016·Mayo Clinic Proceedings·Robert M Jacobson
Jun 23, 2010·BMC Medicine·Robert W JohnsonThomas Weinke
May 30, 2009·BMC Medicine·Paolo BonanniPeter Wutzler
Oct 18, 2011·Virology Journal·Robert Yung-Liang WangRuey-Yi Chang
Sep 10, 2015·PLoS Neglected Tropical Diseases·Vittal MogasaleBinod Sah
Nov 14, 2013·PloS One·Diane M HarperJeffrey Wall
Jun 28, 2016·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Cosby A Stone, Tina V Hartert
Jul 28, 2016·Journal of the American Pharmacists Association : JAPhA·Adam C Welch
Jul 4, 2006·Seminars in Hematology·James Bussel
Aug 16, 2016·Mayo Clinic Proceedings·Matthew R StarrLaura S Greenlund
Oct 26, 2016·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Thomas J MarrieDean T Eurich
Oct 4, 2016·Expert Review of Respiratory Medicine·Catia CillonizAntoni Torres
Dec 29, 2016·International Journal of Molecular Sciences·Nicola Principi, Susanna Esposito
Jan 28, 2017·Journal of the American Medical Directors Association·David A NaceUNKNOWN Infection Advisory Committee for AMDA—The Society of Post-Acute and Long-Term Care Medicine
May 5, 2017·MMWR. Surveillance Summaries : Morbidity and Mortality Weekly Report. Surveillance Summaries·Walter W WilliamsAmy Parker Fiebelkorn
Jun 28, 2017·The Lancet Infectious Diseases·Tetsuya TanimotoKenzo Takahashi
Jul 29, 2017·CA: a Cancer Journal for Clinicians·Elizabeth M WardRobert A Bednarczyk
May 2, 2018·Medical Sciences : Open Access Journal·Catia CillónizAntoni Torres
Mar 25, 2016·Clinical and Vaccine Immunology : CVI·Ioanna Papadatou, Vana Spoulou
Nov 24, 2017·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Gregory S King, William R Judd

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Related Papers

MMWR. Morbidity and Mortality Weekly Report
Centers for Disease Control (CDC)
MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Centers for Disease Control and Prevention
© 2021 Meta ULC. All rights reserved